Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | See Remarks | November 17, 2023 | November 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,015 |
Reported balance
After 2023-11-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-11-17 · Grant · Acquired 698 · Balance 17,015 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023. |
| Common StockSEC Table I · non-derivative | Direct | 16,067 |
Reported balance
After 2023-11-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-11-17 · Tax withholding · Disposed 948 · Balance 16,067 F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 15,183 |
Reported balance
After 2023-11-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2023-11-20 · Sale · Disposed 884 · Balance 15,183 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023.
F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2019 Filed May 15, 2019 22:06 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 788 | $33.76 | $26,602.88 |
DisclosureSEC source: 0001209191-19-030124 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,083 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 22:06 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,041 | $33.76 | $68,904.16 |
DisclosureSEC source: 0001209191-19-030124 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,871 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,133 | $39.80 | $45,093.40 |
DisclosureSEC source: 0001209191-19-006928 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,912 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 3,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006928 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,045 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2017. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 23:41 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 9,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058813 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,871 F1 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/18, until fully vested on 10/31/2021. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:43 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 3,286 | $37.54 | $123,356.44 |
DisclosureSEC source: 0001209191-18-057019 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,305 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2018 Filed Jul 27, 2022 22:42 UTC Amendment | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 3,286 | $37.54 | $123,356.44 |
DisclosureSEC source: 0001209191-22-043294 · doc4a.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,442 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units and deferred stock units. Read SEC document |
| October 31, 2018 Filed Jul 27, 2022 22:42 UTC Amendment | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 3,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043294 · doc4a.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,728 F1 · shares: Reflects shares released on October 31, 2018 in connection with the vesting of performance-based market stock units granted on October 31, 2017. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 23:00 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,853 | $55.00 | $156,915.00 |
DisclosureSEC source: 0001209191-18-039313 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,591 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated November 22, 2017. F2 · balance_after: Includes 53 shares acquired under the Issuer's employee stock purchase plan in May 2018. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 00:54 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 641 | $45.00 | $28,845.00 |
DisclosureSEC source: 0001209191-18-010558 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,391 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated November 22, 2017. F2 · balance_after: Includes 50 shares acquired under the Issuer's employee stock purchase plan in November 2017. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:14 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 9,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-058968 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,982 F3 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2017, until fully vested on 10/31/2020. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:14 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,214 | $37.12 | $45,063.68 |
DisclosureSEC source: 0001209191-17-058968 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,571 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. F2 · balance_after: Includes 32 shares acquired under the Issuer's employee stock purchase plan in May 2017. Read SEC document |
| August 04, 2017 Filed Aug 7, 2017 23:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $45.32 | $0.00 |
DisclosureSEC source: 0001209191-17-047990 · doc4.xml · derivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575 Underlying: Common Stock · 3,575 shares Expires 2024-08-04 F1 · derivative.exercise_date: 33% of the total number of shares subject to the option shall vest and become exercisable one year following the vesting commencement date of August 4, 2017, with the remaining 2/3rds vesting quarterly until fully vested on August 4, 2020. Read SEC document |
| May 01, 2017 Filed May 2, 2017 22:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 76 | $53.65 | $4,077.40 |
DisclosureSEC source: 0001209191-17-029350 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,753 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| April 28, 2017 Filed May 2, 2017 22:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001209191-17-029350 · doc4.xml · derivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575 Underlying: Common Stock · 3,575 shares Expires 2024-04-28 F2 · derivative.exercise_date: 33% of the total number of shares subject to the option shall vest and become exercisable one year following the vesting commencement date of April 28, 2017, with the remaining 2/3rds vesting quarterly until fully vested on April 28, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 22:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 91 | $56.38 | $5,130.58 |
DisclosureSEC source: 0001209191-17-007214 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,829 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. F2 · balance_after: Includes 33 shares acquired under the Issuer's employee stock purchase plan in November 2016. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 00:40 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $54.36 | $0.00 |
DisclosureSEC source: 0001209191-17-006247 · doc4.xml · derivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575 Underlying: Common Stock · 3,575 shares Expires 2024-01-27 F1 · derivative.exercise_date: 33% of the total number of shares subject to the option shall vest and become exercisable one year following the vesting commencement date of January 27, 2017, with the remaining 2/3rds vesting quarterly until fully vested on January 27, 2020. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 23:37 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 735 | $52.12 | $38,308.20 |
DisclosureSEC source: 0001209191-16-147734 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,887 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 23:37 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-16-147734 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575 Underlying: Common Stock · 3,575 shares Expires 2023-10-28 F3 · derivative.exercise_date: 33% of the total number of shares subject to the option shall vest and become exercisable one year following the vesting commencement date of 10/28/2016, with the remaining 2/3rds vesting quarterly until fully vested on October 28, 2019. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 23:37 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147734 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,622 F1 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2016, until fully vested on 10/31/2019. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 20:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,526 | $65.00 | $99,190.00 |
DisclosureSEC source: 0001209191-16-145387 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,922 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 13, 2016. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 20:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 278 | $0.00 Strike: $46.08 | $0.00 |
DisclosureSEC source: 0001209191-16-145387 · doc4.xml · derivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 Underlying: Common Stock · 278 shares Expires 2020-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total number of shares subject to the option vested and became exercisable on November 4, 2014, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 4th day of each month thereafter until fully vested on November 4, 2016. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 20:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 278 | $60.00 | $16,680.00 |
DisclosureSEC source: 0001209191-16-145387 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,448 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 13, 2016. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 20:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 278 | $46.08 | $12,810.24 |
DisclosureSEC source: 0001209191-16-145387 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 22:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 277 | $0.00 Strike: $46.08 | $0.00 |
DisclosureSEC source: 0001209191-16-140993 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557 Underlying: Common Stock · 277 shares Expires 2020-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total number of shares subject to the option vested and became exercisable on November 4, 2014, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 4th day of each month thereafter until fully vested on November 4, 2016. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 22:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 277 | $60.00 | $16,620.00 |
DisclosureSEC source: 0001209191-16-140993 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,448 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 13, 2016. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 22:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 277 | $46.08 | $12,764.16 |
DisclosureSEC source: 0001209191-16-140993 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.